echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Clin Res Cardiol: The impact of COVID-19 on the prevalence of cardiovascular and metabolic diseases in China

    Clin Res Cardiol: The impact of COVID-19 on the prevalence of cardiovascular and metabolic diseases in China

    • Last Update: 2021-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Many studies have shown medsci.


    medsci.


    Researchers searched the Embase and PubMed databases, included studies that summarized the incidence of cardiovascular and metabolic diseases of COVID-19, and compared the incidence of comorbidities in ICU/critical and non-ICU/critical patients.


     

    A total of 6 studies were included in this meta-analysis, including 1527 patients.


    diabetes

    In summary, the results of this meta-analysis show that patients with previous cardiovascular and metabolic diseases are at greater risk of contracting COVID-19 and are more likely to develop severe illnesses.


     

    Original source:

     

    Bo Li, et al.


    Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.